| 2026-05-21 |
详情>>
内部人交易：
Stetter Mark股份增加1572.00股
|
| 2026-05-07 |
详情>>
股本变动：
变动后总股本41922.81万股
|
| 2026-05-07 |
详情>>
业绩披露：
2026年一季报每股收益1.42美元,归母净利润6.01亿美元,同比去年增长-4.75%
|
| 2026-05-07 |
财报披露：
美东时间 2026-05-07 盘前发布财报
|
| 2026-04-08 |
股东大会：
将于2026-05-20召开股东大会
会议内容 ▼▲
- 1.Election of twelve directors until the 2027 Annual Meeting of Shareholders for a one year term
2.Advisory vote to approve our executive compensation
3.Advisory vote to approve the frequency of future advisory votes on our executive compensation
4.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026
5.Shareholder proposal to permit shareholder action by written consent
6.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2026-02-12 |
详情>>
业绩披露：
2023年年报每股收益5.08美元,归母净利润23.44亿美元,同比去年增长10.88%
|
| 2026-02-12 |
详情>>
业绩披露：
2025年年报每股收益6.03美元,归母净利润26.73亿美元,同比去年增长7.52%
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益4.65美元,归母净利润20.70亿美元,同比去年增长8.66%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益3.02美元,归母净利润13.49亿美元,同比去年增长10.30%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益1.41美元,归母净利润6.31亿美元,同比去年增长5.34%
|
| 2025-04-09 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Election of twelve directors until the 2026 Annual Meeting of Shareholders for a one year term
2.Advisory vote to approve our executive compensation
3.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2025
4.Shareholder proposal regarding a special shareholder meeting improvement
5.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2025-02-13 |
详情>>
业绩披露：
2022年年报每股收益4.51美元,归母净利润21.14亿美元,同比去年增长3.78%
|
| 2025-02-13 |
详情>>
业绩披露：
2024年年报每股收益5.47美元,归母净利润24.86亿美元,同比去年增长6.06%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益4.18美元,归母净利润19.05亿美元,同比去年增长4.73%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益1.31美元,归母净利润5.99亿美元,同比去年增长8.51%
|
| 2024-04-10 |
股东大会：
将于2024-05-22召开股东大会
会议内容 ▼▲
- 1.Election of twelve directors until the 2025 Annual Meeting of Shareholders for a one-year term
2.Advisory vote to approve our executive compensation
3.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2024
4.Approval of an amendment to our Restated Certificate of Incorporation to provide for exculpation of officers as permitted by the Delaware General Corporation Law
5.Shareholder proposal regarding an improvement to our director resignation policy
6.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2023-04-06 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.Election of eight directors until the 2024 Annual Meeting of Shareholders for a one-year term
2.Advisory vote to approve our executive compensation
3.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2023
4.Approval of an amendment to our Restated Certificate of Incorporation to create a right to call a special meeting
5.Shareholder proposal regarding ability to call a special meeting
6.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2023-01-24 |
复牌提示：
2023-01-24 09:30:15 停牌，复牌日期 2023-01-24 09:35:15
|
| 2022-04-06 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.Election of Class III Directors until the 2025 Annual Meeting of Shareholders for a three-year term (or until the 2023 Annual Meeting of Shareholders for a one-year term if Item 6 is approved and the Declassification Amendment is filed and becomes effective) as set forth in this proxy statement
2.Advisory vote to approve our executive compensation
3.Approval of an amendment and restatement of our 2013 Equity and Incentive Plan
4.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2022
5.Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc.
6.Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors
7.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-06 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.Election of Class II Directors until the 2024 Annual Meeting of Shareholders for a three-year term as set forth in this proxy statement
2.Advisory vote to approve the company’s executive compensation (Say on Pay)
3.Ratify the appointment of KPMG LLP as the company’s independent registered public accounting firm for 2021
4.Vote on a shareholder proposal regarding simple majority vote, if properly presented at the meeting
5.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2020-04-06 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.Election of Class I Directors until the 2023 Annual Meeting of Shareholders for a three-year term as set forth in this proxy statement
2.An advisory vote to approve the company’s executive compensation (Say on Pay)
3.An advisory vote on the frequency of future advisory votes on executive compensation (Say on Pay Frequency)
4.Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for 2020
5.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2020-02-11 |
除权日：
美东时间 2020-04-16 每股派息0.20美元
|
| 2019-12-11 |
除权日：
美东时间 2020-01-16 每股派息0.20美元
|
| 2019-10-03 |
除权日：
美东时间 2019-10-21 每股派息0.16美元
|
| 2019-05-15 |
除权日：
美东时间 2019-07-18 每股派息0.16美元
|
| 2019-04-02 |
股东大会：
将于2019-05-15召开股东大会
会议内容 ▼▲
- 1.Election of Class III Directors until the 2022 Annual Meeting of Shareholders for a three-year term as set forth in this proxy statement
2.An advisory vote to approve the company’s executive compensation (Say on Pay)
3.Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for 2019
4.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2019-02-12 |
除权日：
美东时间 2019-04-17 每股派息0.16美元
|
| 2018-12-12 |
除权日：
美东时间 2019-01-17 每股派息0.16美元
|
| 2018-10-10 |
除权日：
美东时间 2018-11-19 每股派息0.13美元
|
| 2018-05-15 |
除权日：
美东时间 2018-07-19 每股派息0.13美元
|
| 2018-04-02 |
股东大会：
将于2018-05-15召开股东大会
会议内容 ▼▲
- 1.Election of Class II Directors until the 2021 Annual Meeting of Shareholders for a three-year term as set forth in this proxy statement
2.An advisory vote to approve the company’s executive compensation (Say on Pay)
3.Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for 2018
4.Such other business as may properly come before the Annual Meeting of Shareholders
|
| 2018-02-13 |
除权日：
美东时间 2018-04-19 每股派息0.13美元
|
| 2017-12-11 |
除权日：
美东时间 2018-01-18 每股派息0.13美元
|
| 2017-10-05 |
除权日：
美东时间 2017-11-08 每股派息0.11美元
|
| 2017-05-11 |
除权日：
美东时间 2017-06-13 每股派息0.11美元
|
| 2017-03-31 |
股东大会：
将于2017-05-11召开股东大会
会议内容 ▼▲
- 1.Election of Class I Directors until the 2020 Annual Meeting of Shareholders for a three-year term as set forth in this proxy statement
2.An advisory vote to approve the company’s executive compensation (Say on Pay)
3.Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for 2017
4.Such other business as may properly come before the Annual Meeting
|
| 2017-02-14 |
除权日：
美东时间 2017-04-04 每股派息0.11美元
|
| 2016-12-06 |
除权日：
美东时间 2017-01-18 每股派息0.11美元
|
| 2016-10-06 |
除权日：
美东时间 2016-11-01 每股派息0.10美元
|
| 2016-05-12 |
除权日：
美东时间 2016-06-28 每股派息0.10美元
|
| 2016-02-19 |
除权日：
美东时间 2016-04-05 每股派息0.10美元
|
| 2015-12-16 |
除权日：
美东时间 2016-01-19 每股派息0.10美元
|
| 2015-10-01 |
除权日：
美东时间 2015-11-03 每股派息0.08美元
|
| 2015-07-21 |
除权日：
美东时间 2015-08-11 每股派息0.08美元
|
| 2015-02-27 |
除权日：
美东时间 2015-04-07 每股派息0.08美元
|
| 2014-12-17 |
除权日：
美东时间 2015-01-20 每股派息0.08美元
|
| 2014-10-02 |
除权日：
美东时间 2014-11-03 每股派息0.07美元
|
| 2014-07-31 |
除权日：
美东时间 2014-08-18 每股派息0.07美元
|
| 2014-03-26 |
除权日：
美东时间 2014-04-24 每股派息0.07美元
|
| 2013-12-19 |
除权日：
美东时间 2014-01-28 每股派息0.07美元
|
| 2013-09-12 |
除权日：
美东时间 2013-10-30 每股派息0.07美元
|
| 2013-06-20 |
除权日：
美东时间 2013-07-30 每股派息0.07美元
|
| 2013-03-28 |
除权日：
美东时间 2013-04-29 每股派息0.07美元
|